Dual Antiplatelet Therapy After Stenting in All-Comers, ACS Patients and in High Bleeding Risk

doi 10.3990/1.9789036548892
Full Text
Abstract

Available in full text

Date

Unknown

Authors
Publisher

University Library/University of Twente

Related search

Letter: Bleeding in Cirrhotics Receiving Coronary Stenting and Antiplatelet Therapy

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2017English

Dual Antiplatelet Therapy Duration After Coronary Stenting in Clinical Practice: Results of an EAPCI Survey

EuroIntervention
MedicineCardiovascular MedicineCardiology
2015English

Cardiovascular and Bleeding Risk of Non-Cardiac Surgery in Patients on Antiplatelet Therapy

Journal of Cardiology
Cardiovascular MedicineCardiology
2014English

Dual Antiplatelet or Dual Antithrombotic Therapy for Secondary Prevention in High-Risk Patients With Stable Coronary Artery Disease?

Thrombosis and Haemostasis
Hematology
2019English

CAR 6. Dual Antiplatelet Therapy and Clopidogrel “Resistance” in Carotid Stenting: Preliminary Results

Journal of Vascular Surgery
SurgeryCardiovascular MedicineCardiology
2018English

Efficacy and Safety of Triple Therapy Versus Dual Antiplatelet Therapy in Patients With Atrial Fibrillation Undergoing Coronary Stenting: A Meta-Analysis

PLoS ONE
Multidisciplinary
2018English

Myocardial Infarction Risk After Discontinuation of Thienopyridine Therapy in the Randomized DAPT Study (Dual Antiplatelet Therapy)Clinical Perspective

Circulation
Cardiovascular MedicinePhysiologyCardiology
2017English

Dual Antiplatelet Therapy in Ischemic Stroke

Turk Beyin Damar Hastaliklar Dergisi
NeurologyCardiovascular MedicineCardiology
2019English

Individual Long-Term Variation of Platelet Reactivity in Patients With Dual Antiplatelet Therapy After Myocardial Infarction

Platelets
MedicineHematology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy